(Q28576048)

2

1 reference

31 January 2017

J. Howard James

3

1 reference

31 January 2017

Ayesha Yahya

4

1 reference

31 January 2017

Nijiati Kadeer

5

1 reference

31 January 2017

Xialing Guo

6

1 reference

31 January 2017

Chun Xiao

7

1 reference

31 January 2017

Dorothy M. Supp

8

1 reference

31 January 2017

Richard J. Kagan

9

1 reference

31 January 2017

Per-Olof Hasselgren

10

1 reference

31 January 2017

Sulaiman Sheriff

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

11

1 reference

31 January 2017

1 October 2007

1 reference

31 January 2017

1 reference

31 January 2017

293

1 reference

31 January 2017

4

1 reference

31 January 2017

R1545–1551

1 reference

31 January 2017

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Systemic response to thermal injury in rats. Accelerated protein degradation and altered glucose utilization in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Corticosterone binding globulin regulation and thymus changes after thermal injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

GSK-3beta inhibitors reduce protein degradation in muscles from septic rats and in dexamethasone-treated myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Pharmacological inhibitors of glycogen synthase kinase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

GSK-3beta negatively regulates skeletal myotube hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Growth hormone and IGF-I therapy in the hypercatabolic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007

Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00244.2007